Cargando…

A Path-Based Analysis of Infected Cell Line and COVID-19 Patient Transcriptome Reveals Novel Potential Targets and Drugs Against SARS-CoV-2

Mostrar otras versiones (1)

Most transcriptomic studies of SARS-CoV-2 infection have focused on differentially expressed genes, which do not necessarily reveal the genes mediating the transcriptomic changes. In contrast, exploiting curated biological network, our PathExt tool identifies central genes from the differentially ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Piyush, Sambaturu, Narmada, Olgun, Gulden, Hannenhalli, Sridhar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284228/ https://www.ncbi.nlm.nih.gov/pubmed/35844595 http://dx.doi.org/10.3389/fimmu.2022.918817

Ejemplares similares

A path-based analysis of infected cell line and COVID-19 patient transcriptome reveals novel potential targets and drugs against SARS-CoV-2
por: Agrawal, Piyush, et al.
Publicado: (2022)

miRSCAPE - inferring miRNA expression from scRNA-seq data
por: Olgun, Gulden, et al.
Publicado: (2022)

Predicting gene expression changes upon epigenomic drug treatment
por: Agrawal, Piyush, et al.
Publicado: (2023)

Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
por: Vignesh, Ramachandran, et al.
Publicado: (2020)

EpiTracer - an algorithm for identifying epicenters in condition-specific biological networks
por: Sambaturu, Narmada, et al.
Publicado: (2016)

High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals
por: Prokop, Jeremy W., et al.
Publicado: (2021)

Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation
por: Guvench, Olgun
Publicado: (2015)

Broad misappropriation of developmental splicing profile by cancer in multiple organs
por: Singh, Arashdeep, et al.
Publicado: (2022)

Correction: sRNAscanner: A Computational Tool for Intergenic Small RNA Detection in Bacterial Genomes
por: Sridhar, Jayavel, et al.
Publicado: (2010)

Immunomodulatory Drugs in the Management of SARS-CoV-2
por: Burrage, Daniel R., et al.
Publicado: (2020)

Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2
por: Agrawal, Sudhanshu, et al.
Publicado: (2021)

Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections
por: Chattopadhyay, Partha, et al.
Publicado: (2022)

Network-based approach elucidates critical genes in BRCA subtypes and chemotherapy response in Triple Negative Breast Cancer
por: Agrawal, Piyush, et al.
Publicado: (2023)

Antigenic Determinants of SARS-CoV-2-Specific CD4(+) T Cell Lines Reveals M Protein-Driven Dysregulation of Interferon Signaling
por: Gazzinelli-Guimaraes, Pedro H., et al.
Publicado: (2022)

Prospects of Neutralizing Nanobodies Against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2021)

Defending against SARS-CoV-2: The T cell perspective
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2023)

Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor
por: Khan, Faez Iqbal, et al.
Publicado: (2022)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
por: Bibert, Stéphanie, et al.
Publicado: (2021)

Heterogeneity of transcription factor binding specificity models within and across cell lines
por: Sharmin, Mahfuza, et al.
Publicado: (2016)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Enhancer network revealed by correlated DNAse HS states of enhancers
por: Malin, Justin, et al.
Publicado: (2012)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

BCG mediated protection of the lung against experimental SARS-CoV-2 infection
por: Hilligan, Kerry L., et al.
Publicado: (2023)

An Integrated Transcriptomics and Lipidomics Analysis Reveals That Ergosterol Is Required for Host Defense Against Bacterial Infection in Drosophila
por: Deng, Zihao, et al.
Publicado: (2022)

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches
por: Hoque, M. Nazmul, et al.
Publicado: (2022)

CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro
por: Ma, Minh Tuyet, et al.
Publicado: (2021)

Enhancer networks revealed by correlated DNAse hypersensitivity states of enhancers
por: Malin, Justin, et al.
Publicado: (2013)

A pathway-centric view of spatial proximity in the 3D nucleome across cell lines
por: Karathia, Hiren, et al.
Publicado: (2016)

Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
por: Markewitz, Robert, et al.
Publicado: (2022)

Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections
por: Kurahashi, Yukiya, et al.
Publicado: (2022)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
por: Ahluwalia, Pankaj, et al.
Publicado: (2021)

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety
por: Svorcova, Monika, et al.
Publicado: (2022)

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
por: Monzon-Posadas, Werner O., et al.
Publicado: (2023)

A novel mRNA vaccine, SYS6006, against SARS-CoV-2
por: Xu, Ke, et al.
Publicado: (2023)

Role of genetic heterogeneity in determining the epidemiological severity of H1N1 influenza
por: Sambaturu, Narmada, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_771pun6v29piq2il8ht78qvui8